1. Home
  2. REAX vs INDP Comparison

REAX vs INDP Comparison

Compare REAX & INDP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo The Real Brokerage Inc.

REAX

The Real Brokerage Inc.

HOLD

Current Price

$2.00

Market Cap

435.9M

Sector

N/A

ML Signal

HOLD

Logo Indaptus Therapeutics Inc.

INDP

Indaptus Therapeutics Inc.

HOLD

Current Price

$2.52

Market Cap

350.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
REAX
INDP
Founded
2018
2000
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
435.9M
350.4M
IPO Year
2021
2021

Fundamental Metrics

Financial Performance
Metric
REAX
INDP
Price
$2.00
$2.52
Analyst Decision
Strong Buy
Analyst Count
5
0
Target Price
$5.49
N/A
AVG Volume (30 Days)
4.4M
152.2K
Earning Date
05-07-2026
05-11-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$23.04
N/A
Revenue Next Year
$15.98
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.55
$0.92
52 Week High
$5.41
$10.91

Technical Indicators

Market Signals
Indicator
REAX
INDP
Relative Strength Index (RSI) 49.48 45.65
Support Level $1.92 $2.42
Resistance Level $2.30 $3.11
Average True Range (ATR) 0.16 0.21
MACD -0.01 -0.06
Stochastic Oscillator 37.95 24.14

Price Performance

Historical Comparison
REAX
INDP

About REAX The Real Brokerage Inc.

The Real Brokerage Inc is a technology-powered real estate brokerage firm located in the United States and Canada. It has developed a proprietary transaction management and brokerage operations software called reZEN, which powers nearly all of its brokerage operations, enabling efficiency, automation, and flexibility by incorporating end-to-end transaction management, automated compliance and brokerage oversight, integrated payments and financial services, Leo CoPilot, and open API for customization. In addition, the company also offers mortgage brokering and title services. The company's operating segments are North American Brokerage, which derives key revenue, One Real Title, One Real Mortgage, and Real Wallet. Geographically, it derives key revenue from the United States.

About INDP Indaptus Therapeutics Inc.

Indaptus Therapeutics Inc is a clinical biotechnology company that has developed a novel and patented systemically-administered anti-cancer and anti-viral immunotherapy. Its approach is based on the hypothesis that efficient activation of both innate and adaptive immune cells and associated anti-tumor and anti-viral immune responses will require a multi-targeted package of immune system activating signals that can be administered safely intravenously. Its patented technology is composed of single strains of attenuated and killed, non-pathogenic, Gram-negative bacteria, designed to have reduced i.v. toxicity, but largely uncompromised ability to prime or activate many of the cellular components of innate and adaptive immunity. Its candidate, Decoy20 is for patients with solid tumors.

Share on Social Networks: